Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 3
2013 2
2015 3
2016 1
2017 4
2018 3
2019 2
2020 9
2021 4
2022 8
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Overview of the Global and US Burden of Preterm Birth.
Ward VC, Lee AC, Hawken S, Otieno NA, Mujuru HA, Chimhini G, Wilson K, Darmstadt GL. Ward VC, et al. Among authors: mujuru ha. Clin Perinatol. 2024 Jun;51(2):301-311. doi: 10.1016/j.clp.2024.02.015. Epub 2024 Apr 4. Clin Perinatol. 2024. PMID: 38705642 Review.
Unlocking the global health potential of dried blood spot cards.
Bota B, Ward V, Lamoureux M, Santander E, Ducharme R, Hawken S, Potter BK, Atito R, Nyamanda B, Munga S, Otieno N, Chakraborty S, Saha S, Stringer JS, Mwape H, Price JT, Mujuru HA, Chimhini G, Magwali T, Chakraborty P, Darmstadt GL, Wilson K. Bota B, et al. Among authors: mujuru ha. J Glob Health. 2022 Jul 16;12:03027. doi: 10.7189/jogh.12.03027. J Glob Health. 2022. PMID: 35841606 Free PMC article. No abstract available.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM, Ford D; ODYSSEY trial team. Turkova A, et al. Among authors: mujuru ha. Lancet Child Adolesc Health. 2023 Oct;7(10):718-727. doi: 10.1016/S2352-4642(23)00164-5. Epub 2023 Aug 8. Lancet Child Adolesc Health. 2023. PMID: 37562418 Free article. Clinical Trial.
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
Jacobs TG, Mumbiro V, Cassia U, Zimba K, Nalwanga D, Ballesteros A, Domínguez-Rodríguez S, Tagarro A, Madrid L, Mutata C, Chitsamatanga M, Bwakura-Dangarembizi M, Passanduca A, Buck WC, Nduna B, Chabala C, Najjingo E, Musiime V, Moraleda C, Colbers A, Mujuru HA, Rojo P, Burger DM; EMPIRICAL Clinical Trial Group. Jacobs TG, et al. Among authors: mujuru ha. Clin Infect Dis. 2024 Mar 20;78(3):702-710. doi: 10.1093/cid/ciad656. Clin Infect Dis. 2024. PMID: 37882611 Free PMC article. Clinical Trial.
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial.
Turner RM, Turkova A, Moore CL, Bamford A, Archary M, Barlow-Mosha LN, Cotton MF, Cressey TR, Kaudha E, Lugemwa A, Lyall H, Mujuru HA, Mulenga V, Musiime V, Rojo P, Tudor-Williams G, Welch SB, Gibb DM, Ford D, White IR; the ODYSSEY Trial Team. Turner RM, et al. Among authors: mujuru ha. BMC Med Res Methodol. 2022 Feb 20;22(1):49. doi: 10.1186/s12874-022-01539-3. BMC Med Res Methodol. 2022. PMID: 35184739 Free PMC article.
Delays in presentation of intussusception and development of gangrene in Zimbabwe.
Mazingi D, Burnett E, Mujuru HA, Nathoo K, Tate J, Mwenda J, Weldegebriel G, Manangazira P, Mukaratirwa A, Parashar U, Zimunhu T, Mbuwayesango BA. Mazingi D, et al. Among authors: mujuru ha. Pan Afr Med J. 2021 Jul 28;39(Suppl 1):3. doi: 10.11604/pamj.supp.2021.39.1.21301. eCollection 2021. Pan Afr Med J. 2021. PMID: 34548895 Free PMC article.
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
Turkova A, White E, Mujuru HA, Kekitiinwa AR, Kityo CM, Violari A, Lugemwa A, Cressey TR, Musoke P, Variava E, Cotton MF, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch SB, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe GM, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb DM; ODYSSEY Trial Team. Turkova A, et al. Among authors: mujuru ha. N Engl J Med. 2021 Dec 30;385(27):2531-2543. doi: 10.1056/NEJMoa2108793. N Engl J Med. 2021. PMID: 34965338 Free PMC article. Clinical Trial.
50 results